1 / 8

Telmisartan Market To Surpass US$ 4.3 Billion By 2026 - Coherent Market Insights

u201cCoherent Market Insights u201cTELMISARTAN MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Telmisartan Market To Surpass US$ 4.3 Billion By 2026 - Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TELMISARTAN MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Telmisartan Market - Overview The Global Telmisartan Market, by Strength (20mg, 40mg, and 80mg), by Indication (Hypertension, Cardiac Arrest, and Stroke,), Combinational), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), was valued at US$ 3,880.9 million in 2017, and is projected to exhibit a CAGR of 1.4% over the forecast period (2018 - 2026). by Composition (Single and Telmisartan is a prescription medication often prescribed to relax and widen blood vessels in persons with high blood pressure. Telmisartan belongs to a group of drugs called angiotensin II receptor blockers (ARBs). Telmisartan may be used alone or in combination with other medications such as hydrochlorothiazide for treatment of high blood pressure. Increasing awareness regarding hypertension and its management by organizing global campaigns are expected to drive growth of the market. For instance, in May 2017, Argentinian Society of Hypertension (SAHA) participated in global campaigns named May Measurement Month and World Hypertension Day for creating awareness among population related to blood pressure and their management. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/telmisartan-market-2524 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Browse 23 Market Data Tables and 19 Figures spread through 157 Pages and in-depth TOC on ”Global Telmisartan Market" by Strength (20mg, 40mg, and 80mg), by Indication (Hypertension, Cardiac Arrest, and Stroke), by Composition (Single and Combinational), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Forecast to 2026" Key players are focused on development and launch of new generic product to maximize access to end users for their product in less cost, in turn gaining market share in telmisartan market. For instance, in June 2017, Solco Healthcare, announced its FDA approval for Telmisartan tablets, 20mg, 40mg, and 80mg, which are AB-rated equivalents to Micardis by Boehringer Ingelheim. Solco Healthcare will market Telmisartan tablets in 30 count bottles for all three strengths. Moreover, increasing government initiatives for hypertension management is expected to drive growth of the global Telmisartan market. For instance, in December 2017, the Secretary, Ministry of Health and Family Welfare (MOHFW) and Secretary, Department of Health Research (DHR) and Director General, Indian Council of Medical Research (ICMR) launched, the India Hypertension Management Initiative (IHMI). The IHMI aims to reduce disability and death related to cardiovascular disease (CVD), by improving control over high blood pressure (hypertension), reducing salt consumption from food, and eliminating artificial trans-fats, which are leading risk factors for developingCVD. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2524 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Key Takeaways of the Telmisartan Market: The global telmisartan market is expected to expand at a CAGR of 1.4% during the forecast period (2018 – 2026), owing to continuous marketing approvals for telmisartan. Among strength, 80 mg segment is expected to hold leading position in the global telmisartan market, owing to approval from USFDA of telmisartan 80 mg in combination with other drugs. For instance, in September 2016, Nippon Boehringer Ingelheim Co., Ltd. and Astellas Pharma Inc. received the manufacturing and marketing approval for Micatrio combination tablets from US FDA. Tablet comprises of telmisartan (concentration 80mg), amlodipine besylate, and hydrochlorothiazide (HCTZ). Such manufacturing and marketing approvals for telmisartan promote their growth in global market during the forecast period. Major players operating in the global telmisartan market include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2524 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related